167 related articles for article (PubMed ID: 22842985)
1. Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women.
Agboola AJ; Musa AA; Wanangwa N; Abdel-Fatah T; Nolan CC; Ayoade BA; Oyebadejo TY; Banjo AA; Deji-Agboola AM; Rakha EA; Green AR; Ellis IO
Breast Cancer Res Treat; 2012 Sep; 135(2):555-69. PubMed ID: 22842985
[TBL] [Abstract][Full Text] [Related]
2. Molecular profiling of breast cancer in Nigerian women identifies an altered p53 pathway as a major mechanism underlying its poor prognosis compared with British counterpart.
Agboola AO; Banjo AA; Anunobi CC; Ayoade BA; Deji-Agboola AM; Musa AA; Abdel-Fatah T; Nolan CC; Rakha EA; Ellis IO; Green AR
Malays J Pathol; 2014 Apr; 36(1):3-17. PubMed ID: 24763230
[TBL] [Abstract][Full Text] [Related]
3. PIASγ expression in relation to clinicopathological, tumour factors and survival in indigenous black breast cancer women.
Agboola A; Musa A; Banjo A; Ayoade B; Deji-Agboola M; Nolan C; Rakha E; Ellis I; Green A
J Clin Pathol; 2014 Apr; 67(4):301-6. PubMed ID: 24170211
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and molecular characteristics of Ku 70/80 expression in Nigerian breast cancer and its potential therapeutic implications.
Agboola AO; Ebili HO; Iyawe VO; Banjo AA; Salami BA; Rakha EA; Nolan CC; Ellis IO; Green AR
Pathol Res Pract; 2017 Jan; 213(1):27-33. PubMed ID: 27914769
[TBL] [Abstract][Full Text] [Related]
5. Tumour cell membrane laminin expression is associated with basal-like phenotype and poor survival in Nigerian breast cancer.
Agboola AO; Ebili HO; Iyawe VO; Banjo AA; Salami BS; Rakha EA; Nolan C; Ellis IO; Green AR
Malays J Pathol; 2016 Aug; 38(2):83-92. PubMed ID: 27568664
[TBL] [Abstract][Full Text] [Related]
6. The microRNA maturation regulator Drosha is an independent predictor of outcome in breast cancer patients.
Khoshnaw SM; Rakha EA; Abdel-Fatah T; Nolan CC; Hodi Z; Macmillan RD; Ellis IO; Green AR
Breast Cancer Res Treat; 2013 Jan; 137(1):139-53. PubMed ID: 23225145
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and molecular significance of Sumolyation marker (ubiquitin conjugating enzyme 9 (UBC9)) expression in breast cancer of black women.
Agboola AO; Musa AA; Ayoade BA; Banjo AA; Anunobi CC; Deji-Agboola AM; Rakha EA; Nolan C; Ellis IO; Green AR
Pathol Res Pract; 2014 Jan; 210(1):10-7. PubMed ID: 24176171
[TBL] [Abstract][Full Text] [Related]
8. Lack of expression of the proteins GMPR2 and PPARα are associated with the basal phenotype and patient outcome in breast cancer.
Baker BG; Ball GR; Rakha EA; Nolan CC; Caldas C; Ellis IO; Green AR
Breast Cancer Res Treat; 2013 Jan; 137(1):127-37. PubMed ID: 23208589
[TBL] [Abstract][Full Text] [Related]
9. Loss of Dicer expression is associated with breast cancer progression and recurrence.
Khoshnaw SM; Rakha EA; Abdel-Fatah TM; Nolan CC; Hodi Z; Macmillan DR; Ellis IO; Green AR
Breast Cancer Res Treat; 2012 Sep; 135(2):403-13. PubMed ID: 22821364
[TBL] [Abstract][Full Text] [Related]
10. US breast cancer mortality trends in young women according to race.
Ademuyiwa FO; Gao F; Hao L; Morgensztern D; Aft RL; Ma CX; Ellis MJ
Cancer; 2015 May; 121(9):1469-76. PubMed ID: 25483625
[TBL] [Abstract][Full Text] [Related]
11. Cell Proliferation (KI-67) Expression Is Associated with Poorer Prognosis in Nigerian Compared to British Breast Cancer Women.
Agboola AO; Banjo AA; Anunobi CC; Salami B; Agboola MD; Musa AA; Nolan CC; Rakha EA; Ellis IO; Green AR
ISRN Oncol; 2013; 2013():675051. PubMed ID: 23691362
[TBL] [Abstract][Full Text] [Related]
12. Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer.
Abduljabbar R; Negm OH; Lai CF; Jerjees DA; Al-Kaabi M; Hamed MR; Tighe PJ; Buluwela L; Mukherjee A; Green AR; Ali S; Rakha EA; Ellis IO
Breast Cancer Res Treat; 2015 Apr; 150(2):335-46. PubMed ID: 25762479
[TBL] [Abstract][Full Text] [Related]
13. Histological Features and Tissue Microarray Taxonomy of Nigerian Breast Cancer Reveal Predominance of the High-Grade Triple-Negative Phenotype.
Titloye NA; Foster A; Omoniyi-Esan GO; Komolafe AO; Daramola AO; Adeoye OA; Adisa AO; Manoharan A; Pathak D; D'Cruz MN; Alizadeh Y; Lewis PD; Shaaban AM
Pathobiology; 2016; 83(1):24-32. PubMed ID: 26730581
[TBL] [Abstract][Full Text] [Related]
14. Strong association of fascin expression with triple negative breast cancer and basal-like phenotype in African-American women.
Esnakula AK; Ricks-Santi L; Kwagyan J; Kanaan YM; DeWitty RL; Wilson LL; Gold B; Frederick WA; Naab TJ
J Clin Pathol; 2014 Feb; 67(2):153-60. PubMed ID: 23986556
[TBL] [Abstract][Full Text] [Related]
15. Incidence, mortality and receptor status of breast cancer in African Caribbean women: Data from the cancer registry of Guadeloupe.
Deloumeaux J; Gaumond S; Bhakkan B; Manip M'Ebobisse N; Lafrance W; Lancelot P; Vacque D; Negesse Y; Diedhiou A; Kadhel P
Cancer Epidemiol; 2017 Apr; 47():42-47. PubMed ID: 28119121
[TBL] [Abstract][Full Text] [Related]
16. Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.
Tan F; Mosunjac M; Adams AL; Adade B; Taye O; Hu Y; Rizzo M; Ofori-Acquah SF
BMC Cancer; 2014 Sep; 14():715. PubMed ID: 25255861
[TBL] [Abstract][Full Text] [Related]
17. Does race predict survival for women with invasive breast cancer?
Walsh SM; Zabor EC; Stempel M; Morrow M; Gemignani ML
Cancer; 2019 Sep; 125(18):3139-3146. PubMed ID: 31206623
[TBL] [Abstract][Full Text] [Related]
18. Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein.
Alshareeda AT; Negm OH; Aleskandarany MA; Green AR; Nolan C; TigHhe PJ; Madhusudan S; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2016 Aug; 159(1):41-53. PubMed ID: 27464795
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological characteristics of oestrogen receptor negative, progesterone receptor positive breast cancers: re-evaluating subsets within this group.
Ahmed SS; Thike AA; Zhang K; Lim JC; Tan PH
J Clin Pathol; 2017 Apr; 70(4):320-326. PubMed ID: 27612503
[TBL] [Abstract][Full Text] [Related]
20. Pathological, clinical and prognostic characteristics of breast cancer in Central Sudan versus Northern Italy: implications for breast cancer in Africa.
Awadelkarim KD; Arizzi C; Elamin EO; Hamad HM; De Blasio P; Mekki SO; Osman I; Biunno I; Elwali NE; Mariani-Costantini R; Barberis MC
Histopathology; 2008 Mar; 52(4):445-56. PubMed ID: 18315597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]